New Perspectives on Antifungal Therapy

Author(s): Fernando de Carvalho da Silva, Debora Omena Futuro, Luana da Silva Magalhães Forezi.

Journal Name: Current Pharmaceutical Design

Volume 26 , Issue 14 , 2020

Become EABM
Become Reviewer

[1]
e Silva KSF, Silva LC, Gonçales RA, Neves BJ, Soares CMA, Pereira M. Setting new routes for antifungal drug discovery against pathogenic fungi. Curr Pharm Des 2020; 26(14): 1509-20.
[2]
Wasan KM. Development of an oral amphotericin B formulation as an alternative approach to parenteral amphotericin b administration in the treatment of blood-borne fungal infections. Curr Pharm Des 2020; 26(14): 1521-3.
[3]
Pereira LD, Vila T, Borba-Santosa LP, de Souza W, Navarro M. Activity of metal-azole complexes against biofilms of Candida albicans and Candida glabrata. Curr Pharm Des 2020; 26(14): 1524-31.
[4]
Maximino SC, Dutra JAP, Rodrigues RP, et al. Synthesis of eugenol derivatives and evaluation of their anti-fungal activity against Fusarium solanio f. sp. piperis. Curr Pharm Des 2020; 26(14): 1532-42.
[5]
Kılıç MED, Kahraman E, Güngör S, Özsoy Y. Optimization and characterization of aqueous micellar formulations for ocular delivery of an antifungal drug, Posaconazole. Curr Pharm Des 2020; 26(14): 1543-55.
[6]
de Lima LC, Ramos MAS, de Toledo LG, et al. Syngonanthus nitens (Bong.) Ruhland derivatives loaded into a lipid nanoemulsion for enhanced antifungal activity against Candida parapsilosis. Curr Pharm Des 2020; 26(14): 1556-65.
[7]
Noronha LL, Ferreira PG, Lima CGS, et al. Formulation and evaluation of a novel itraconazole-clotrimazole topical emulgel for the treatment of sporotrichosis. Curr Pharm Des 2020; 26(14): 1566-70.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 26
ISSUE: 14
Year: 2020
Page: [1507 - 1508]
Pages: 2
DOI: 10.2174/138161282614200515114950

Article Metrics

PDF: 16
HTML: 2